Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis

[1] Hirahara N(2016)Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy BMC Surg 20 66-4222

[2] Matsubara T(2017)Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery Anticancer Res 37 4215-2760

[3] Mizota Y(2017)Pretreatment combination of platelet counts and neutrophil-lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy Onco Targets Ther 10 2751-1850

[4] Ishibashi S(2016)Sosiho-tang ameliorates cachexia-related symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss Oncol Rep 35 1841-32

[5] Tajima Y(2017)The Evolving Approach to Management of Cancer Cachexia Oncology (Williston Park) 31 23-3367

[6] Mimatsu K(2015)Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells Mol Med Rep 11 3361-1315

[7] Fukino N(2015)Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer Eur J Surg Oncol 41 1308-12420

[8] Ogasawara Y(2015)Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients World J Gastroenterol 21 12410-1005

[9] Saino Y(1984)Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients [in Japanese] Nihon Geka Gakkai Zasshi 85 1001-123

[10] Oida T(2011)Japanese gastriccancer treatment guidelines 2010 (ver.3) Gastric Cancer 14 113-263

[1] Hirahara N(2016)Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy BMC Surg 20 66-4222

[2] Matsubara T(2017)Utility of Inflammatory Marker- and Nutritional Status-based Prognostic Factors for Predicting the Prognosis of Stage IV Gastric Cancer Patients Undergoing Non-curative Surgery Anticancer Res 37 4215-2760

[3] Mizota Y(2017)Pretreatment combination of platelet counts and neutrophil-lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy Onco Targets Ther 10 2751-1850

[4] Ishibashi S(2016)Sosiho-tang ameliorates cachexia-related symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss Oncol Rep 35 1841-32

[5] Tajima Y(2017)The Evolving Approach to Management of Cancer Cachexia Oncology (Williston Park) 31 23-3367

[6] Mimatsu K(2015)Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells Mol Med Rep 11 3361-1315

[7] Fukino N(2015)Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer Eur J Surg Oncol 41 1308-12420

[8] Ogasawara Y(2015)Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients World J Gastroenterol 21 12410-1005

[9] Saino Y(1984)Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients [in Japanese] Nihon Geka Gakkai Zasshi 85 1001-123

[10] Oida T(2011)Japanese gastriccancer treatment guidelines 2010 (ver.3) Gastric Cancer 14 113-263